Ovizio
- Company typePrivate
- Founded2010
- HeadquartersBrussels, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Ovizio firmographics
Firmographics- Name
- Ovizio
- Legal name
- Ovizio Imaging Systems NV/SA
- Website
- https://ovizio.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Ovizio industry classification
Industry- Product category
- Cell Analysis Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Laboratory Analytical Instruments (3826), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
Keywords
Where Ovizio is headquartered
LocationHeadquarters
- HQ city
- Brussels
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
Ovizio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Consumables: Sale of consumable products including cassettes, slides, and reagents for use with holographic microscopy instruments.
- Service Contracts: Service and support contracts for existing instruments, generating recurring revenue from installed customer base.
Ovizio product offering
Product offeringCore offering
Ovizio develops and sells digital holographic interferometric microscopy-based cell counters and analyzers for the bioprocessing and cell and gene therapy industries. Its flagship product, the iLine F PRO Analyzer, performs real-time, label-free, automated cell counting and analysis with 21 CFR Part 11/GMP-ready software for regulated manufacturing. The company also sells consumables (cassettes, slides, reagents) and recurring service contracts supporting its installed instruments.
Product overview
Ovizio was a Belgian company specializing in holographic microscopy-based cell counters for bioprocessing and cell and gene therapy applications. The company's primary product was the iLine F PRO Analyzer, a live cell analyzer providing real-time, label-free cell analysis with automated process analytical technology capabilities. Ovizio was acquired by ChemoMetec A/S in October 2024 and now operates under ChemoMetec's portfolio. ChemoMetec has positioned its XcytoMatic 30 and 40 instruments as alternatives for customers seeking different cell counting solutions, while continuing to support existing Ovizio instruments.
Differentiator
Problem solved
Functional benefit
Brands
- iLine F PRO: Live cell analyzer with real-time and automated process analytical technology, label-free cell analysis, maximized availability of biological sample, and 21 CFR Part 11/GMP-ready software.
Products and services
- iLine F PRO Analyzer Live cell analyzer providing real-time, automated process analytical technology (PAT) with label-free cell analysis. Maximizes availability of biological samples and features 21 CFR Part 11/GMP-ready software for regulated bioprocessing and cell and gene therapy manufacturing environments.
- Holographic Microscopy Consumables Consumables including cassettes, slides, and reagents designed for use with Ovizio's holographic microscopy instruments, sold to bioprocessing and cell therapy customers as recurring-use items paired with installed analyzers.
- Service and Support Contracts Service and support contracts covering maintenance, qualification, and application support for installed Ovizio holographic microscopy instruments, including post-acquisition support delivered through ChemoMetec's team of Field Application Scientists and Service Engineers.
Companies that use Ovizio
Customer profileSegments2 records
Ideal customer profiles2 records
Ovizio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature1 record
Ovizio partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights3 records
Ovizio competitors and assessment
Company assessmentBroad incumbents
- ChemoMetec A/S: ChemoMetec is the parent company of Ovizio and the most direct peer, offering NucleoCounter and XcytoMatic cell counters for bioprocessing and cell therapy. Highly comparable in product category and customer base, now a platform rather than competitor.
- Beckman Coulter Life Sciences: Part of Danaher, Beckman Coulter offers Vi-Cell and other automated cell counters and analyzers used in bioprocessing and cell therapy. Overlaps directly with Ovizio's cell counting and viability use cases with a much broader life sciences portfolio.
- Sartorius AG: Sartorius is a major bioprocessing supplier whose cell analysis and process monitoring instruments serve overlapping customers with Ovizio. Broad incumbent with much larger scale and workflow integration.
- Cytiva: Cytiva (formerly GE Healthcare Life Sciences) provides bioprocessing and cell therapy manufacturing solutions, including cell counting and analysis tools. Overlaps in customer base and process analytical technology positioning.
- Thermo Fisher Scientific: Thermo Fisher provides Countess and other automated cell counters, plus a broad life sciences and bioprocessing portfolio. Comparable cell counting use cases with vastly broader distribution and instrument breadth.
- Becton, Dickinson and Company (BD): BD offers flow cytometry and cell analysis instruments (e.g., BD FACSDiscover) serving cell therapy and immunology research customers. Overlaps with Ovizio in cell analysis workflows but at much larger scale.
Direct peers
- Revvity (Nexcelom Bioscience): Revvity acquired Nexcelom, a direct competitor in automated cell counting (Celigo, Cellometer) for cell and gene therapy and bioprocessing workflows. Closely comparable instrument platform and target customers.
- Logos Biosystems: Logos Biosystems manufactures the Luna and LUNA-FL automated cell counters, including bright-field and fluorescence imaging-based systems for cell therapy and bioprocessing. Directly competes with Ovizio's iLine F PRO in label-free cell counting.
- DeNovix Inc. DeNovix offers the CellDrop automated cell counter, a label-free, direct-count instrument targeting similar bioprocessing and cell therapy customers. Comparable in technology approach (no-staining, image-based counting).
Others
- Agilent Technologies: Agilent provides cell analysis and bioprocess analytical solutions, including the NovoCyte flow cytometer. Adjacent in cell analysis and bioprocessing instrumentation rather than direct holographic imaging competition.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Ovizio social profiles
Digital presenceOvizio compliance and trust
Trust signalCompliance2 records
Ovizio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ovizio leadership team
Management profileNumber of profiles
Profiles3 records
Ovizio funding detail
Funding detailFunding overview
Funding rounds2 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ovizio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ovizio
What does Ovizio do?
Ovizio develops and sells digital holographic interferometric microscopy-based cell counters and analyzers for the bioprocessing and cell and gene therapy industries. Its flagship product, the iLine F PRO Analyzer, performs real-time, label-free, automated cell counting and analysis with 21 CFR Part 11/GMP-ready software for regulated manufacturing. The company also sells consumables (cassettes, slides, reagents) and recurring service contracts supporting its installed instruments.
Is Ovizio a public or private company?
Ovizio is a private company. It is classified as corporate owned and is currently acquired.
When was Ovizio founded?
Ovizio was founded in 2010. It employs 11 to 50 people.
Where is Ovizio based?
Ovizio is headquartered in Brussels, Belgium, in the Europe region.
How does Ovizio make money?
Two revenue lines are on record. Consumables are the primary driver. The others are service Contracts.
Who are Ovizio's main competitors?
Broad incumbents on record are ChemoMetec A/S, Beckman Coulter Life Sciences, Sartorius AG, Cytiva, Thermo Fisher Scientific and Becton, Dickinson and Company (BD). Direct peers are Revvity (Nexcelom Bioscience), Logos Biosystems and DeNovix Inc.. Agilent Technologies is listed as an others.
Does Ovizio have an API?
No public API is recorded for Ovizio.
What industry is Ovizio in?
Ovizio's product category is Cell Analysis Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334516 and its SIC code is 3826.